AnaptysBio Inc at TD Cowen Healthcare Conference Transcript
()-
Alrighty, thank you everyone for for joining us in the room and online for TD Cowan's forty-sixth annual healthcare conference. I'm Jo Tho, one of the senior biotech analysts here on the team at TD Cowan. And it's my pleasure to have with me today Anapti, and we'll hear some maybe some some new names, during the conversation today too. But, for a, overview we have Dan Fega, President and CEO.
So maybe just to start things off and then we'll kind of dive into, the business split and the individual programs, but at a high level, kind of what were the main accomplishments recently with the NAPTIS and what should investors be expecting, for 2026? Obviously you provided the update last night. Yeah.
Thanks, Joe. It's, hard to not be really excited sitting here, today.
A number of months back, we announced that we'd be separating our business, into two publicly traded companies. We did publicly file
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
